Literature DB >> 2549392

Physiological relevance of the changing subunit composition and regulatory properties of the 6-phosphofructo-1-kinase isozyme pools during heart and muscle development.

G A Dunaway1, T P Kasten.   

Abstract

During postnatal development, the subunit compositions of the 6-phosphofructo-1-kinase isozyme pools of heart and skeletal muscle are known to change. The isozyme pools from fetal muscle were composed of the L-type (60%), and M-type (36%) and C-type (4%) subunits and the isozymes from fetal and early neonatal heart contain nearly equal amounts of all three subunits. During postnatal development of both tissues, the proportion of the M-type subunit increases until it is the only type present in adult muscle and the major subunit in adult heart (75%). The isozyme pool from fetal muscle exhibit a decreased affinity for fructose-6-P and a greater susceptibility to ATP inhibition compared to the M-rich isozymes which are subsequently present. The isozyme pools from fetal and early neonatal heart, if compared to the M-rich isozymes which are present later during heart development and to the fetal muscle isozymes, exhibited the least affinity for fructose-6-P and the greatest susceptibility to ATP inhibition. Comparison of the isozyme pools containing little or no C-type subunit with those from fetal and early neonatal heart clearly indicates that the presence of substantial levels of the C-type subunit imposed a decreased ability for fructose-2,6-P2 to both lower affinity for fructose-6-P and antagonize sensitivity to ATP inhibition. Although still not thoroughly appreciated, it appears that the changing nature of the isozyme pools in these tissues permits regulation of glucose metabolism in a manner which allows efficient utilization of nutritional opportunities and which adequately meets the energy requirements of each tissue at different stages of development.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549392     DOI: 10.1007/BF00421084

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Nature of the subunits of the 6-phosphofructo-1-kinase isoenzymes from rat tissues.

Authors:  G A Dunaway; T P Kasten
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

2.  Regulation of skeletal muscle 6-phosphofructo-1-kinase during aging and development.

Authors:  G A Dunaway; T P Kasten; G A Nickols; J A Chesky
Journal:  Mech Ageing Dev       Date:  1986-09       Impact factor: 5.432

3.  Alteration of 6-phosphofructo-1-kinase isozyme pools during heart development and aging.

Authors:  G A Dunaway; T P Kasten; P Kolm
Journal:  J Biol Chem       Date:  1986-12-25       Impact factor: 5.157

Review 4.  Dynamic properties of mammalian skeletal muscles.

Authors:  R I Close
Journal:  Physiol Rev       Date:  1972-01       Impact factor: 37.312

5.  Isozyme composition and phosphorylation of brain phosphofructokinase.

Authors:  L G Foe; R G Kemp
Journal:  Arch Biochem Biophys       Date:  1984-02-01       Impact factor: 4.013

6.  Purification of homogeneous rat phosphofructokinase isozymes with high specific activities.

Authors:  T P Kasten; D Naqui; D Kruep; G A Dunaway
Journal:  Biochem Biophys Res Commun       Date:  1983-03-16       Impact factor: 3.575

7.  Regulation of fructose-2,6-bisphosphate content in rat hepatocytes, perfused hearts, and perfused hindlimbs.

Authors:  L Hue; P F Blackmore; H Shikama; A Robinson-Steiner; J H Exton
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

8.  Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.

Authors:  S Vora; C Seaman; S Durham; S Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

9.  Myocardial enzyme activities in guinea pigs during development.

Authors:  S E Barrie; P Harris
Journal:  Am J Physiol       Date:  1977-12

10.  Fructose-2,6-P2, chemistry and biological function.

Authors:  K Uyeda; E Furuya; C S Richards; M Yokoyama
Journal:  Mol Cell Biochem       Date:  1982-10-18       Impact factor: 3.396

View more
  6 in total

1.  Alteration of the levels of the M-type 6-phosphofructo-1-kinase mRNA isoforms during neonatal maturation of heart, brain and muscle.

Authors:  Y Mhaskar; G Armour; G Dunaway
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

2.  Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21.

Authors:  A Elson; D Levanon; Y Weiss; Y Groner
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

3.  Regulation of brain 6-phosphofructo-1-kinase: effects of aging, fructose-2,6-bisphosphate, and regional subunit distribution.

Authors:  T P Kasten; Y Mhaskar; G A Dunaway
Journal:  Mol Cell Biochem       Date:  1993-03-10       Impact factor: 3.396

4.  Characterization of phosphofructokinase-deficient canine erythrocytes.

Authors:  J W Harvey; M G Pate; Y Mhaskar; G A Dunaway
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

5.  Citrate inhibition of rat-kidney cortex phosphofructokinase.

Authors:  M M Sola; F J Oliver; R Salto; M Gutiérrez; A Vargas
Journal:  Mol Cell Biochem       Date:  1994-06-29       Impact factor: 3.396

6.  The subunit proportions and kinetic properties of 6-phosphofructo-1-kinase isozymes from rat heart atria and ventricle progressively change during aging.

Authors:  Y Mhaskar; G A Dunaway
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.